OPOKU, Yeboah Kwaku et al. Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells. EXCLI Journal, [S. l.], v. 19, p. 567–581, 2020. DOI: 10.17179/excli2020-1287. Disponível em: https://www.excli.de/index.php/excli/article/view/2232. Acesso em: 25 apr. 2024.